Shanghai Fosun Pharmaceutical Q3 Profit Rises 15% on One-off Gains

Key Facts

1Shanghai Fosun Pharmaceutical's Q3 net profit rose 15% year-on-year, driven by extraordinary one-off gains.

2Revenue grew 1.4% to 10 billion yuan, though earnings would have declined by 8% without the one-off gains.

Shanghai Fosun Pharmaceutical's net profit rose 15% year-on-year in the third quarter of 2026. Yahoo Finance reported that the increase was driven by extraordinary one-off gains, while revenue grew by 1.4% to reach 10 billion yuan during the period.

The company's underlying earnings faced pressure from lower income related to joint ventures and out-licensing projects, with profit otherwise set to decline by 8% without the one-off items. These results indicate a slowdown in core operations despite the reported increase in headline net income.